Emmaus Life Sciences, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - June 20, 2011

Attached files

file filename
S-1/A - AMENDED REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - Emmaus Life Sciences, Inc.v226200_s1a.htm
EX-10.53 - FORM OF AMENDMENT TO STOCK OPTION AGREEMENT - Emmaus Life Sciences, Inc.v226200_ex10-53.htm
EX-10.52 - FORM OF AGREEMENT TO AMEND WARRANTS ISSUED ON JULY 5, 2010 - Emmaus Life Sciences, Inc.v226200_ex10-52.htm
EX-10.51 - FORM OF AGREEMENT TO AMEND PLACEMENT AGENT WARRANTS - Emmaus Life Sciences, Inc.v226200_ex10-51.htm
EX-10.50 - FORM OF AGREEMENT TO CONVERT AND AMEND - Emmaus Life Sciences, Inc.v226200_ex10-50.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM

We hereby consent to the use of our report dated December 20, 2010 except for note 13, as to which the date is June 17, 2011, with respect to the consolidated financial statements of CNS Response, Inc. and its subsidiaries which expresses an unqualified opinion and includes an explanatory paragraph relating to a going concern uncertainty for the three-year period ended September 30, 2010, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
 
/s/ Cacciamatta Accountancy Corporation      
  
CACCIAMATTA ACCOUNTANCY CORPORATION      
         
Irvine, California        
June 20, 2011        
 
 
 
 

Emmaus Life Sciences, Inc. Reports

Also read